Stay updated on Satralizumab in Thyroid Eye Disease Clinical Trial

Sign up to get notified when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Satralizumab in Thyroid Eye Disease Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    15 days ago
    Change Detected
    Summary
    The value on the webpage has changed from April 11 to May 10, indicating an update in the study details related to the efficacy, safety, pharmacokinetics, and pharmacodynamics of Satralizumab in participants with Thyroid Eye Disease.
    Difference
    0.9%
    Check dated 2024-05-11T19:37:41.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    The classic website content has been updated to inform users that it will no longer be available as of June 25, 2024, and they are advised to use the modernized ClinicalTrials.gov instead. This change may impact users monitoring medical and healthcare-related publications and documentation on the webpage.
    Difference
    1%
    Check dated 2024-05-06T18:55:24.000Z thumbnail image

Stay in the know with updates to Satralizumab in Thyroid Eye Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.